Pharma Equity Group A/S Class A PEG
OMXCOP · Danimarka · Sağlık Teknolojisi
DKK 0,0778+0,00 (+%2,10)
Piyasa açık· · DKK · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa açık· · DKK · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
07 September 2026 Announcement no. 11 Pharma Equity Group A/S – Challenge to Arbitral Award Pharma Equity Group A/S (“PEG”) has been notified that Interpatium – Promoção Imobiliária LDA has commenced proceedings before the District Court of Helsingør seeking to have the arbitral award dated 12 June 2026 set aside. PEG disputes the grounds for the proceedings and will protect the Company’s interests throughout the legal process. The commencement of the proceedings does not in itself suspend the e
Correction to Consolidated Interim Report 1 January – 30 June 202614 August 2026Announcement no. 10 The previous announcement with the half year report was missing the report. The announcement is re-published, including the report. On 14 August 2026, the Board of Directors and the Executive Board of Pharma Equity Group A/S ("PEG", "The Company" or the "Group") considered and approved the interim report for the Group for the period 1 January – 30 June 2026 ("H1 2026 report"), which can be summari
12 June 2026 Announcement no. 8 Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs Pharma Equity Group A/S ("PEG" or the "Company") today announces that it has received a final and binding international arbitral award rendered by the Danish Institute of Arbitration in the proceedings against Interpatium – Promoção Imobiliária LDA, Madeira, Portugal. The Arbitral Tribunal has ruled entirely in favour of PEG and awarde
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.